Riskpilot← Back to searchSign inGet full accessDemegårds Optik i Falköping AB
ABActiveOrg 5567857031Nya Stadens Torg 6Retail sale of medical and orthopaedic goods · NACE 4774Est. 20096 employees
Revenue 2025
SEK 13,6M
+8% vs 2024
EBITDA margin
10.4%
+61% vs 2024
Equity ratio
25.3%
Financial strength
Net profit 2025
SEK 289K
+89% vs 2024
| Revenue | SEK 13,6M | +8% |
| EBITDA | SEK 1,4M | +61% |
| Net profit | SEK 289K | +89% |
| Total assets | SEK 6,2M | +9% |
| Equity | SEK 1,6M | +23% |
| Employees | 6 | — |
Legal name
Demegårds Optik i Falköping AB
Org number
5567857031
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
8 juli 2009
Share capital
SEK 100 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolagets verksamhet ska vara att bedriva utprovning samt försäljning av glasögon och kontaktlinser jämte därmed förenlig verksamhet.
Address
Nya Stadens Torg 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 11 688 | 13 180 | 11 824 | 12 558 | 13 556 |
| Staff expenses | — | −2 662 | −2 367 | −3 316 | −3 688 |
| EBITDA | 3 000 | 3 359 | 1 787 | 880 | 1 415 |
| Depreciation & amort. | −78 | −211 | −205 | −259 | −324 |
| EBIT | 2 922 | 3 148 | 1 582 | 621 | 1 092 |
| Net financials | 2 | −58 | 31 | −2 | 461 |
| Profit before tax | 72 | 100 | 113 | 219 | 289 |
| Tax | −21 | −36 | −13 | −66 | — |
| Net profit | 51 | 64 | 101 | 153 | 289 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 344 | 3 656 | 3 212 | 5 654 | 6 169 |
| Equity | 957 | 1 021 | 1 122 | 1 274 | 1 563 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 3 127 | 2 385 | 1 841 | 2 530 | 2 859 |
| Total debt | 3 127 | 2 385 | 1 841 | 2 530 | 2 859 |
EBITDA margin
10.4%
This company
15.8%
Market median
-34% vs market
20212025
Equity ratio
25.3%
This company
38.2%
Market median
-34% vs market
20212025
Return on equity
18.5%
This company
18.4%
Market median
+1% vs market
20212025
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
20212025
Asset turnover
2.20×
This company
1.12×
Market median
+96% vs market
20212025
Debt / equity
2.95×
This company
0.62×
Market median
-376% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CP Chief Executive Officer | Chief Executive Officer | 2021 |
KC Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
HG | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Demegårds Optik AB
Demegårds Optik i Falköping AB Board members of Demegårds Optik i Falköping AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Patrick Demegård | Chief Executive Officer | 0 companies |
| Hans Gustaf Claes Buder | Audit | 0 companies |
| Kjell Christer Larsson | Chief Auditor | 0 companies |
| Karin Maria Demegård | Deputy Board Member | 0 companies |
| Helen Kerstin Maria Demegård | Deputy Board Member | 0 companies |
| Jens Tobias Demegård | Chairman | 0 companies |